Blood Transcriptome Response to Environmental Metal Exposure Reveals Potential Biological Processes Related to Alzheimer's Disease

Blood Transcriptome Response to Environmental Metal Exposure Reveals Potential Biological Processes Related to Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disease which is manifested by a progressive and irreversible decline of cognition, memory loss, a shortened attention span, and changes in personality. Aging and genetic pre-dispositions, particularly the presence of a specific form of apolipopro...

Full description

Bibliographic Details
Main Authors:	Julian Krauskopf, Ingvar A. Bergdahl, Anders Johansson, Domenico Palli, Thomas Lundh, Soterios A. Kyrtopoulos, Theo M. de Kok, Jos C. Kleinjans
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Public Health
Subjects:	Alzheimer's disease metals gene expression transcriptomics microarray APOE
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2020.557587/full

Similar Items

MicroRNA profile for health risk assessment: Environmental exposure to persistent organic pollutants strongly affects the human blood microRNA machinery
by: Julian Krauskopf, et al.
Published: (2017-08-01)

Multiple Transcriptomic Analyses Explore Potential Synaptic Biomarker Rabphilin-3A for Alzheimer's Disease
by: Doan Phuong Quy Nguyen, et al.
Published: (2024-08-01)

Differential Transcriptome Profiling Unveils Novel Deregulated Gene Signatures Involved in Pathogenesis of Alzheimer’s Disease
by: Himanshu Narayan Singh, et al.
Published: (2022-03-01)

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
by: Nicholas F. Fitz, et al.
Published: (2020-07-01)

APOE2 is associated with longevity independent of Alzheimer’s disease
by: Mitsuru Shinohara, et al.
Published: (2020-10-01)

Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis
by: Panagiotis Georgiadis, et al.
Published: (2017-09-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)

The APOEε3/ε4 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice
by: Kate E. Foley, et al.
Published: (2022-03-01)

Lead-exposure associated miRNAs in humans and Alzheimer’s disease as potential biomarkers of the disease and disease processes
by: Qingfeng Wen, et al.
Published: (2022-09-01)

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
by: Mohammed Amir Husain, et al.
Published: (2021-02-01)

Gene expression studies in autism: Moving from the genome to the transcriptome and beyond
by: Irina Voineagu
Published: (2012-01-01)

Association study of the GAB2 gene with the risk of developing Alzheimer's disease
by: Julien Chapuis, et al.
Published: (2008-04-01)

APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
by: Sheina Emrani, et al.
Published: (2020-11-01)

APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease
by: Michal Prendecki, et al.
Published: (2019-05-01)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
by: Wu P, et al.
Published: (2015-01-01)

Chronic RNA G-quadruplex accumulation in aging and Alzheimer’s disease
by: Lena Kallweit, et al.
Published: (2025-02-01)

APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease
by: Ai-Ling Lin, et al.
Published: (2020-06-01)

Newborn sex-specific transcriptome signatures and gestational exposure to fine particles: findings from the ENVIRONAGE birth cohort
by: Ellen Winckelmans, et al.
Published: (2017-06-01)

Apolipoprotein E and Alzheimer’s Disease in Italian Population: Systematic Review and Meta-Analysis
by: Diana Marisol Abrego-Guandique, et al.
Published: (2024-09-01)

Editorial: Expert opinions on the relationship between microglia, glia, and Alzheimer's disease: 2022
by: Angela Gomez-Arboledas, et al.
Published: (2023-09-01)

Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women With Alzheimer’s Disease
by: Manish D. Paranjpe, et al.
Published: (2021-09-01)

The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease
by: Celia G. Fernandez, et al.
Published: (2019-02-01)

Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer’s Disease
by: Jiajia Fu, et al.
Published: (2022-05-01)

Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia
by: Brandon Ebright, et al.
Published: (2022-10-01)

Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population
by: de-Andrade F.M., et al.
Published: (2000-01-01)

APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain
by: Iliya Lefterov, et al.
Published: (2019-12-01)

Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer’s Disease and Cardiovascular Diseases
by: Chun Xu, et al.
Published: (2021-12-01)

Machine Learning Approach to Identify Case-Control Studies on ApoE Gene Mutations Linked to Alzheimer’s Disease in Italy
by: Giorgia Francesca Saraceno, et al.
Published: (2024-02-01)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
by: Stephanie R. Oatman, et al.
Published: (2023-01-01)

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study
by: Niklas Mattsson, et al.
Published: (2018-08-01)

Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
by: Marco Zuin, et al.
Published: (2021-05-01)

Association of cancer history with Alzheimer’s disease onset and structural brain changes
by: Kelly Nicole Holohan Nudelman, et al.
Published: (2014-10-01)

Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma
by: Zaatar Adel M, et al.
Published: (2012-09-01)

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease
by: Janne Marieke Herden, et al.
Published: (2023-06-01)

Cholesterol and ApoE in Alzheimer’s disease
by: Potier Marie-Claude, et al.
Published: (2018-07-01)

Synapses, Microglia, and Lipids in Alzheimer’s Disease
by: Patrick J. Paasila, et al.
Published: (2022-01-01)

Identification of a specific APOE transcript and functional elements associated with Alzheimer’s disease
by: Qiang Chen, et al.
Published: (2024-08-01)

Toward an Early Diagnosis for Alzheimer’s Disease Based on the Perinuclear Localization of the ATM Protein
by: Elise Berthel, et al.
Published: (2023-06-01)

BioTEA: Containerized Methods of Analysis for Microarray-Based Transcriptomics Data
by: Luca Visentin, et al.
Published: (2022-09-01)

Unveiling mitochondria as central components driving cognitive decline in alzheimer's disease through cross-transcriptomic analysis of hippocampus and entorhinal cortex microarray datasets
by: Pajaree Sonsungsan, et al.
Published: (2024-10-01)